Natural Capsules Ltd.

BSE: 524654 SECTOR: Pharmaceuticals & Drugs  10k   34   1

436.70
-12.25 (-2.73%)
BSE: 26 May 05:10 PM

Price Summary

Today's High

₹ 450

Today's Low

₹ 435

52 Week High

₹ 679

52 Week Low

₹ 0

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

408.27 Cr.

Enterprise Value

436.37 Cr.

No. of Shares

0.93 Cr.

P/E

19.51

P/B

3.78

Face Value

₹ 10

Div. Yield

0.23 %

Book Value (TTM)

₹  115.58

CASH

2.99 Cr.

DEBT

31.08 Cr.

Promoter Holding

56.56 %

EPS (TTM)

₹  22.39

Sales Growth

69.86%

ROE

19.22 %

ROCE

23.14%

Profit Growth

100.86 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Natural Capsules Ltd.

Veenat Lenalid Erlonat Geftinat Sorafenat Bortenat

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year69.86%
3 Year31.22%
5 Year20.28%

Profit Growth

1 Year99.86%
3 Year92.77%
5 Year85.41%

ROE%

1 Year19.22%
3 Year10.86%
5 Year7.62%

ROCE %

1 Year23.14%
3 Year13.81%
5 Year9.91%

Debt/Equity

0.3742

Price to Cash Flow

80.18

Interest Cover Ratio

10.3315880488039

CFO/PAT (5 Yr. Avg.)

1.02966656354763

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 56.56 0
Dec 2022 56.56 0
Sep 2022 56.56 0
Jun 2022 56.57 0
Mar 2022 56.57 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 93.6853600149358% for the Past 3 years.
  • The company has shown a good revenue growth of 31.2179664011432% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 10.3315880488039.
  • Company’s PEG ratio is 0.248360152671855.
  • The company has an efficient Cash Conversion Cycle of -16.0560379088163 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.02966656354763.
  • The company has a high promoter holding of 56.56%.

 Limitations

  • Company has contingent liabilities of 96.7313 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
Net Sales 37.61 41.55 44.19 45.06 45.5
Total Expenditure 29.91 33.36 35.01 35.39 35.8
Operating Profit 7.7 8.19 9.18 9.67 9.7
Other Income 0.06 0.73 0.21 0.04 0.01
Interest 0.57 0.67 0.62 0.72 0.95
Depreciation 1.25 1.39 1.63 1.96 1.74
Exceptional Items 0 0 0 0 0
Profit Before Tax 5.94 6.86 7.14 7.03 7.02
Tax 1.81 1.76 1.9 1.69 1.77
Profit After Tax 4.13 5.1 5.24 5.34 5.25
Adjusted EPS (Rs) 5.89 7.28 7.48 6.87 5.68

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 54.76 59.78 61.55 79.51 135.07
Total Expenditure 49.22 54.73 56.11 68.38 110.66
Operating Profit 5.53 5.05 5.45 11.14 24.41
Other Income 0.81 1.14 0.95 0.73 2.14
Interest 0.33 0.53 0.91 0.54 2.08
Depreciation 4.33 3.2 4.12 4.31 5.04
Exceptional Items 0 -0.39 0 2.18 0
Profit Before Tax 1.68 2.07 1.37 9.19 19.43
Tax 0.57 0.15 0.51 2.24 5.47
Net Profit 1.11 1.92 0.86 6.88 13.76
Adjusted EPS (Rs.) 1.46 2.53 1.13 9.14 19.9

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 6.23 6.23 6.23 6.23 7.01
Total Reserves 48.09 49.26 49.39 55.9 76.04
Borrowings 0 0 0 0 13.07
Other N/C liabilities 1.88 1.23 1.08 1.55 2.28
Current liabilities 14.86 16.42 17.98 32.98 45.09
Total Liabilities 71.06 73.15 74.68 96.66 143.49
Assets
Net Block 21.88 24.37 23.81 34.59 62.94
Capital WIP 1.03 2.45 2.11 3.45 1.07
Intangible WIP 0 0 0 0 0
Investments 5.07 5.08 5.58 0.02 0.05
Loans & Advances 0.48 2.09 4.69 1.47 1.58
Other N/C Assets 0.96 0.81 0.79 0.78 0.41
Current Assets 41.64 38.35 37.7 56.35 77.44
Total Assets 71.06 73.15 74.68 96.66 143.49
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 1.68 2.07 1.37 9.19 19.43
Adjustment 4.58 3.89 5.03 2.73 6.33
Changes in Assets & Liabilities -0.92 -3.07 1.46 -3.91 -15.92
Tax Paid 0 -0.79 -0.66 -2.22 -4.74
Operating Cash Flow 5.35 2.1 7.2 5.78 5.09
Investing Cash Flow -0.93 -7.06 -5.74 -8.54 -30.42
Financing Cash Flow -3.93 4.28 -1.19 2.52 26.51
Net Cash Flow 0.49 -0.68 0.27 -0.24 1.18

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 56.57 56.57 56.56 56.56 56.56
tajos investments ... - - - 12.34 12.34
tajos investments ... 12.34 12.34 12.34 - -
nandi synthetics p... 8.41 8.41 8.41 8.41 8.41
nandi synthetics p... - - - - -
sunil laxminaryan ... 6.67 6.67 6.67 6.67 6.67
sunil laxminarayan... - - - - -
sushil kumar mundra 4.72 5.44 5.44 5.44 5.44
indra mundra 3.47 4.19 4.19 4.19 4.19
jyoti mundra 3.28 3.28 3.28 3.28 3.28
sharada mundra 2.08 2.83 2.83 2.83 2.83
laxminarayan moond... 2.57 2.57 2.57 2.57 2.57
radha s mundra 2.56 2.56 2.56 2.56 2.56
satyanarayan mundra 1.98 1.98 1.98 1.98 1.98
madhav mundra 1.77 1.77 1.77 1.77 1.77
shrey mundra 1.77 1.77 1.77 1.77 1.77
jyotsna daga 0.34 0.34 0.34 0.34 0.34
nidhi sethia 0.16 0.16 0.16 0.16 0.17
chandra r laddha 0.02 0.02 0.02 0.02 0.02
deepak kabra 0.02 0.02 0.02 0.02 0.02
mukund gattani 0.01 0.01 0.01 0.01 0.01
b sampathlal 0.01 0.01 0.01 0.01 0.01
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 43.43 43.43 43.44 43.44 43.44
sangeetha s 5.40 5.40 5.40 5.35 5.32
vivog commercial l... 4.55 4.55 4.55 4.55 4.55
subramanian p - - - - -
mahendra labs pvt ... 4.22 4.22 4.22 4.22 4.22
sanjay kothari - - - - -
chartered finance ... 2.66 2.66 1.52 - -
nisha dudheria 2.65 1.12 1.12 1.12 -
prabha mohta 2.50 2.50 2.50 2.30 2.30
jyotivardhan jaipu... 1.44 1.44 1.44 1.44 1.44
iepf - - 1.39 1.38 1.38
ajita yogesh - - 1.17 - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ3FY23 11 Apr 2023

Company News

Natural Capsules informs about details of loss of certificate 3 May 2023, 3:11PM Natural Capsules informs about annual disclosure28 Apr 2023, 4:25PM Natural Capsules informs about loss of share certificate22 Apr 2023, 12:02PM Natural Capsules informs about details of loss of certificate28 Feb 2023, 4:13PM Natural Capsules - Quaterly Results13 Feb 2023, 6:01PM Natural Capsules - Quaterly Results13 Feb 2023, 6:01PM Natural Capsules informs about trading window closure29 Dec 2022, 3:03PM Natural Capsules’ arm completes maiden fund raise of Rs 18.75 crore21 Nov 2022, 5:15PM Natural Capsules - Quaterly Results28 Oct 2022, 7:13PM Natural Capsules - Quaterly Results28 Oct 2022, 7:13PM Natural Capsules informs about board meeting 21 Oct 2022, 9:53AM Natural Capsules informs about meeting updates20 Sep 2022, 4:27PM Natural Capsules informs about outcome of AGM20 Sep 2022, 1:35PM Natural Capsules informs about loss of share certificate15 Sep 2022, 5:17PM Natural Capsules informs about loss of share certificate13 Sep 2022, 4:57PM Natural Capsules informs about newspaper cuttings12 Aug 2022, 10:26AM Natural Capsules informs about loss of his share certificate28 Jul 2022, 5:02PM Natural Capsules informs about compliances-certificate16 Jul 2022, 4:44PM Natural Capsules informs about loss of share certificate29 Jun 2022, 3:34PM Natural Capsules informs about details of loss of certificate23 Jun 2022, 4:13PM Natural Capsules - Quaterly Results9 May 2022, 7:46PM Natural Capsules - Quaterly Results9 May 2022, 7:46PM Natural Capsules informs about non-applicability of large corporate entity28 Apr 2022, 4:41PM Natural Capsules informs about certificate18 Apr 2022, 5:04PM Natural Capsules informs about analyst meet7 Apr 2022, 2:39PM Natural Capsules - Quaterly Results8 Feb 2022, 6:07PM Natural Capsules - Quaterly Results8 Feb 2022, 6:07PM Natural Capsules informs about clarification9 Dec 2021, 4:58PM Natural Capsules informs about certificate8 Oct 2021, 4:00PM Natural Capsules informs about analyst meet22 Sep 2021, 4:17PM Natural Capsules informs about board meeting2 Aug 2021, 9:52AM Natural Capsules informs about outcome of AGM16 Jul 2021, 11:41AM Natural Capsules gets nod for capacity expansion plan 16 Jul 2021, 10:17AM Natural Capsules informs about compliance certificate12 Jul 2021, 1:05PM Natural Capsules informs about annual secretarial compliance report15 Jun 2021, 12:41PM Natural Capsules incorporates WOS company26 Aug 2020, 9:52AM Natural Capsules informs about voting results21 Aug 2020, 4:15PM

Natural Capsules Stock Price Analysis and Quick Research Report. Is Natural Capsules an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Natural Capsules and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 5.0921 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Natural Capsules has a Debt to Equity ratio of 0.3742 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Natural Capsules , the EPS growth was 117.735617847218 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Natural Capsules has OPM of 18.0703365046459 % which is a good sign for profitability.
     
  • ROE: Natural Capsules have a average ROE of 19.222339620978 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Natural Capsules

X